Pharmaceutical Benefits Regulations (Amendment)

Overview

The Pharmaceutical Benefits Regulations 1952 were enacted under the Pharmaceutical Benefits Act 1947-1950 by the Governor-General in Council, with the aim of updating and refining the existing regulatory framework to better address the evolving needs of the pharmaceutical sector in Australia. This legislative instrument was necessary to amend the Second Schedule of the Pharmaceutical Benefits Regulations, reflecting changes in the pharmaceutical products available and their associated pricing. The regulations sought to ensure that the supply of pharmaceutical benefits could be effectively managed and administered in line with contemporary medical practices and public health needs. The policy objective was to maintain a consistent and accessible supply of essential medications to the Australian public, thereby supporting the broader health outcomes and accessibility goals of the Pharmaceutical Benefits Scheme.

Scope and Application

The Pharmaceutical Benefits Regulations, made under the Pharmaceutical Benefits Act 1947-1950, apply to the regulation of the supply of pharmaceutical benefits in Australia, specifically detailing the price controls and amendments to the list of scheduled items, which includes pharmaceutical drugs and their formulations. These regulations apply to the Commonwealth and each state and territory of Australia, thereby ensuring a uniform national approach to the regulation of pharmaceutical benefits. The regulations cover all entities and persons involved in the supply of pharmaceutical benefits, including pharmaceutical manufacturers, wholesalers, pharmacists, and consumers. Notably, the regulations specify that the amendments made by these statutory rules do not apply to prescriptions written before the date of commencement of these Regulations, thereby preserving the existing price controls for prescriptions submitted before this date. Additionally, the Pharmaceutical Benefits Regulations may be further extended or restricted through subordinate instruments, which can include further amendments or specific provisions to address particular drugs or categories of drugs.

Key Provisions

The main operative sections of these Regulations (referred to as "Regulations") amend the Second Schedule of the Pharmaceutical Benefits Regulations (1). The amendments primarily involve updating the list of pharmaceutical items and their associated prices, including replacing or omitting certain items and introducing new ones. For example, items such as Acetarsol, Adrenalin Tartrate, Aureomycin, Diphtheria Prophylactic, Heparin, Isoprenaline Sulphate, Morphine with Atropine, Pethidine Hydro-chloride, Phenobarbitone, Procaine Penicillin (Aqueous), Procaine Pencillin (Crystalline), and Terramycin are either modified or added to the schedule. These Regulations impose several obligations on the parties they govern. Primarily, they dictate the prices at which certain pharmaceutical benefits can be supplied under the Pharmaceutical Benefits Scheme (PBS). The amendments necessitate that suppliers, such as pharmacists, adhere to these updated prices when dispensing medications listed in the Second Schedule. The Regulations also ensure that any prescriptions written before the date of commencement of these Regulations continue to be honoured at the old prices, as stated in section 2. Violations of these Regulations may lead to legal consequences. While the Regulations themselves do not explicitly detail penalties for non-compliance, the broader Pharmaceutical Benefits Act 1947-1950 and related legislation could impose fines or other penalties for improper adherence to the PBS requirements. These penalties would be enforced under the authority of the Act, and specific details would be found within that Act or other relevant legislative instruments.